HighTower Advisors LLC lessened its position in Tenet Healthcare Corp (NYSE:THC) by 2.2% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 154,065 shares of the company’s stock after selling 3,526 shares during the quarter. HighTower Advisors LLC owned approximately 0.15% of Tenet Healthcare worth $2,201,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of THC. Stonebridge Capital Advisors LLC purchased a new stake in shares of Tenet Healthcare in the 1st quarter valued at approximately $46,000. Advisor Group Holdings Inc. purchased a new stake in shares of Tenet Healthcare in the 1st quarter valued at approximately $57,000. Nisa Investment Advisors LLC lifted its position in shares of Tenet Healthcare by 256.0% in the 1st quarter. Nisa Investment Advisors LLC now owns 4,450 shares of the company’s stock valued at $64,000 after acquiring an additional 3,200 shares in the last quarter. Amundi Pioneer Asset Management Inc. purchased a new stake in shares of Tenet Healthcare in the 4th quarter valued at approximately $111,000. Finally, Aigen Investment Management LP purchased a new stake in shares of Tenet Healthcare in the 1st quarter valued at approximately $121,000. Institutional investors and hedge funds own 99.59% of the company’s stock.

NYSE:THC opened at $18.20 on Tuesday. Tenet Healthcare Corp has a 1 year low of $10.00 and a 1 year high of $39.37. The firm’s fifty day simple moving average is $20.92 and its 200 day simple moving average is $26.04. The company has a current ratio of 1.32, a quick ratio of 1.24 and a debt-to-equity ratio of 29.98. The firm has a market capitalization of $1.84 billion, a PE ratio of -15.42, a PEG ratio of 9.36 and a beta of 2.31.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Monday, May 4th. The company reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.96. Tenet Healthcare had a negative net margin of 0.65% and a positive return on equity of 65.69%. The business had revenue of $4.52 billion for the quarter, compared to analyst estimates of $4.63 billion. During the same period last year, the business posted $0.54 EPS. Tenet Healthcare’s revenue was down .6% compared to the same quarter last year. As a group, analysts anticipate that Tenet Healthcare Corp will post 0.86 EPS for the current fiscal year.

A number of research firms have issued reports on THC. Wells Fargo & Co cut their target price on shares of Tenet Healthcare from $40.00 to $32.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 6th. Barclays increased their target price on shares of Tenet Healthcare from $19.00 to $22.00 and gave the stock an “equal weight” rating in a research report on Monday, May 11th. Mizuho cut their target price on shares of Tenet Healthcare from $32.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, May 29th. Citigroup cut their target price on shares of Tenet Healthcare from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Wednesday, May 20th. Finally, ValuEngine downgraded shares of Tenet Healthcare from a “sell” rating to a “strong sell” rating in a research report on Friday, May 1st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $27.42.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Story: S&P/TSX Index

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.